Xiao-jun Shen

Xiao-jun Shen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
FCFang Cao
Fang Cao
YHYongwei Hu
Yongwei Hu
ZCZaichang Chen
Zaichang Chen
WHWei Han
Wei Han
WLWeijie Lu
Weijie Lu
XSXiao-jun Shen
Xiao-jun Shen
Background: Recent researches have suggested that long noncoding RNA (lncRNA) is involved in the tumorigenesis and development of stomach cancer (SC). This meta-analysis aimed to identify the diagnostic performance of circulating lncRNAs in SC. Methods: All relevant studies were systematically searched through PubMed, Web of Science, Cochrane Library, and EMBASE databases. The diagnostic values of lncRNAs were mainly assessed by pooled sensitivity, specificity, and summary receiver operating characteristic area under the curve (SROC AUC). Meta-DiSc 1.4, Review Manager 5.3, and STATA 12.0 were used for statistical analysis. The protocol for this systematic review was registered on INPLASY (INPLASY202120079) and is available in full on the inplasy.com (10.37766/inplasy2021.2.0079). Results: A total of 42 eligible studies were included in this meta-analysis. The pooled sensitivity, specificity, and SROC AUC were 0.78 (95%CI 0.75–0.81), 0.75 (95%CI 0.71–0.78), and 0.83 (95%CI 0.80–0.86), respectively, suggesting that the lncRNAs test had a high accuracy for the diagnosis of SC. Obvious heterogeneity might come from the type of lncRNA through subgroup and meta-regression analysis. Fagan diagram shows the clinical value of lncRNAs test in SC. Conclusions: Abnormal expression of circulating lncRNAs exhibits a high efficacy for diagnosing SC, which is promising in clinical application.

2 February 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
FWFan Wu
Fan Wu
XSXiao-jun Shen
Xiao-jun Shen
Ultra-low rectal cancer (defined as a tumor located within 5 cm from the anal verge) poses unique challenges owing to its distinctive anatomical location, necessitating an optimal balance between oncologic safety and functional preservation. This review focuses on the clinical progress and technological innovations in sphincter-preserving management for ultra-low rectal cancer and is organized within a hierarchical framework encompassing oncologic/anatomical principles, surgical procedures, operative approaches/platforms, specimen-extraction strategies, and multimodal therapy. We first outline plane-based resection principles centered on total mesorectal excision (TME) and key aspects of margin quality control. We then systematically summarize the spectrum of sphincter-preserving procedures, including low/ultra-low anterior resection (LAR/uLAR) and reconstructive options such as coloanal anastomosis (CAA), the transabdominal–transanal approach (TATA), pull-through procedures (Bacon and its modifications), and intersphincteric resection (ISR), with comparisons of indications, oncologic safety, and functional outcomes. Furthermore, we discuss the impact of laparoscopic, robotic, and transanal approaches (e.g., TaTME) on deep pelvic exposure, anatomical precision, and the learning curve, as well as the trade-offs between minimally invasive benefits and safety control associated with specimen-extraction strategies such as NOSE. Finally, we summarize the role of neoadjuvant and total neoadjuvant therapy in facilitating sphincter or organ preservation. Overall, sphincter-preserving treatment for ultra-low rectal cancer should be guided by standardized oncologic principles and tailored combinations of procedures and approaches, with the overarching goal of balancing functional benefit against oncologic safety.

10 February 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
MLMuyang Liu
Muyang Liu
XSXiao-jun Shen
Xiao-jun Shen
Gastric cancer is the fifth most common malignant tumor worldwide and the third leading cause of cancer-related deaths, posing a serious threat to global public health. Despite notable advancements in surgical techniques, systemic chemotherapy, targeted therapy, and immunotherapy in recent years, the overall prognosis for patients with locally advanced gastric cancer (AGC) remains suboptimal, primarily due to the high propensity for local and distant metastasis. Peritoneal metastasis (PM), in particular, has become one of the most formidable clinical challenges owing to its high incidence, inherent resistance to systemic chemotherapy, and extremely poor prognosis. To address this challenge, Prophylactic Hyperthermic Intraperitoneal Chemotherapy (P-HIPEC) has emerged as a focal point of research. This therapeutic modality aims to eradicate microscopic residual tumors and free cancer cells in the abdominal cavity following radical gastrectomy, thereby effectively reducing the risk of peritoneal metastasis and improving long-term patient survival. This review systematically examines the latest research progress of P-HIPEC in the treatment of gastric cancer, provides an in-depth analysis of its mechanism of action, indications, criteria for patient and drug selection, evidence of clinical efficacy, safety controversies, and challenges in standardization. It also looks forward to future research directions in this field, with the aim of providing a valuable reference for clinical practice and academic research.

11 June 2026 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
MLMuyang Liu
Muyang Liu
XSXiao-jun Shen
Xiao-jun Shen
Patients with primary unilateral indirect inguinal hernias and large internal inguinal rings have a higher incidence of seroma formation following laparoscopic transabdominal preperitoneal (TAPP) hernia repair. This study aims to investigate the clinical efficacy of suturing and closing the internal inguinal ring during the TAPP procedure to reduce the postoperative seroma rate. A retrospective analysis was conducted on the clinical data of 162 patients with primary unilateral indirect inguinal hernias and an internal ring defect diameter of ≥ 3.0 cm, who were treated at Kunshan First People's Hospital from December 2023 to November 2024. All patients underwent the TAPP procedure with hernia sac transection. Based on whether the internal inguinal ring was sutured closed intraoperatively, patients were divided into two groups: an experimental group (internal ring closure, n = 81) and a control group (no internal ring closure, n = 81).The study compared the incidence of postoperative seromas, perioperative indicators (operative time, incision size, blood loss, length of hospital stay, etc.), and other related complications (postoperative pain, sensory abnormalities, infection, urinary retention, testicular edema, etc.) between the two groups, as well as short-term recurrence rates. There were no statistically significant differences in the baseline characteristics between the two groups, and all surgeries were completed successfully. The incidence of seroma in the experimental group at 7 days and 1 month postoperatively was significantly lower than in the control group [8.64% (7/81) vs. 28.40% (23/81), P = 0.002; and 2.47% (2/81) vs. 13.58% (11/81), P = 0.018, respectively]. Regarding severity (Morales-Conde classification), the experimental group recorded 5 Grade I and 2 Grade II cases, with zero Grade III events; whereas the control group observed 12 Grade I, 8 Grade II, and 3 Grade III events. There were no significant differences in seroma incidence between the two groups at 3 months and 6 months postoperatively (P > 0.05). The operative time for the experimental group [(63.67 ± 9.26) min] was slightly longer than that of the control group [(60.21 ± 10.23) min] (t = 2.255, P = 0.025). There were no statistically significant differences in other perioperative indicators, other related complications, or short-term recurrence rates between the two groups (P > 0.05). For primary unilateral indirect inguinal hernias with an internal ring defect diameter of ≥ 3.0 cm, suturing and closing the internal ring defect during the TAPP procedure was associated with a lower rate of seroma formation.

31 August 2026 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
HLHui Li
Hui Li
TSTong Shen
Tong Shen
XSXiao-jun Shen
Xiao-jun Shen
Low rectal cancer lies deep in the pelvis, close to the pelvic autonomic nerves and urogenital structures. Surgery must therefore balance oncological clearance, sphincter preservation, and functional outcomes. Total mesorectal excision (TME) remains the fundamental oncological principle across open, laparoscopic, robotic, and transanal approaches. A deep, narrow male pelvis, obesity, a very low tumor, fibrosis after neoadjuvant treatment, and restricted distal transection can make transabdominal TME technically demanding. Robotic transabdominal TME (rTME) provides three-dimensional high-definition visualization, wristed instruments, tremor filtration, and a stable operating platform. These features address several limitations of conventional laparoscopy. rTME may therefore be suitable for most patients with mid-to-low rectal cancer when distal dissection and transection remain controllable from above. Against this background, the role of transanal total mesorectal excision (TaTME) should be reassessed rather than dismissed. Current evidence neither renders TaTME obsolete nor establishes a universal advantage across all low rectal cancers. Instead, TaTME is better positioned as a selective technical complement for very low tumors, restricted distal exposure or transection, and composite difficult-pelvis scenarios. At the same time, the development of robot-assisted TaTME (R-TaTME), hybrid TaTME, single-port robotic systems, and flexible transanal platforms offers new technological avenues. These platforms may improve procedural stability and instrument dexterity during transanal surgery. This review reappraises TaTME in the robotic era, focusing on indication refinement, pathological quality, training and quality assurance, functional preservation, and platform development.

25 May 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
LGLongmiao Gu
Longmiao Gu
FWFan Wu
Fan Wu
JCJie Cheng
Jie Cheng
XSXiao-jun Shen
Xiao-jun Shen
Gastroesophageal reflux disease is a common gastrointestinal disorder worldwide, with a particularly high prevalence in Western countries, and its incidence has been rising steadily in Asia in recent years. The pathogenesis involves dysfunction of the lower esophageal sphincter, inadequate support of the crural diaphragm, disruption of the His angle and gastroesophageal flap valve, the formation of a postprandial acid pocket, and delayed gastric emptying in some patients. Surgical intervention is required for patients with severe symptoms or complications. Traditional fundoplication provides effective symptom control, but postoperative complications such as dysphagia and gas-bloat syndrome remain concerns; in cases of short esophagus or large hiatal hernia, Collis gastroplasty or mesh reinforcement may be necessary. In recent years, the advancement of minimally invasive techniques has facilitated the application of robot-assisted surgery, magnetic sphincter augmentation, transoral incisionless fundoplication, and lower esophageal sphincter electrical stimulation, which emphasize minimal invasiveness, functional preservation, and individualized approaches. Whether the concept of “asymptomatic elective repair”, as applied in inguinal hernia, can be extended to certain hiatal hernia patients remains to be further explored.